Evidence map›Paper›PMID 26344566›Full record

ArticleNature cell biology2015

ATM functions at the peroxisome to induce pexophagy in response to ROS.

Jiangwei Zhang, Durga Nand Tripathi, Ji Jing, Angela Alexander, Jinhee Kim, Reid T Powell, Ruhee Dere, Jacqueline Tait-Mulder, Ji-Hoon Lee, Tanya T Paull and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 259 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
259citing papers in PubMed, 2 pooled it
26.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

259 citing papers in PubMed, 2 syntheses or guidelines pooled it, 418 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. The Extended Lifespan ofCurrent issues in molecular biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. ATM interaction with GRP94 modulates oncogenic receptor expression and signaling and microglial activation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Review

199 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Jiangwei Zhang *Center for Translational Cancer Research, Institute for Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA.
Durga Nand Tripathi *Center for Translational Cancer Research, Institute for Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA.
Ji Jing *Center for Translational Cancer Research, Institute for Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA.
Angela AlexanderDepartment of Experimental Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA.
Jinhee KimKorea Institute of Oriental Medicine, Dajeon, 305-811, South Korea.
Reid T PowellCenter for Translational Cancer Research, Institute for Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA.
Ruhee DereCenter for Translational Cancer Research, Institute for Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA.
Jacqueline Tait-MulderDepartments of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Ji-Hoon LeeThe Howard Hughes Medical Institute, Department of Molecular Genetics and Microbiology, University of Texas, Austin, TX 78712.
Tanya T PaullThe Howard Hughes Medical Institute, Department of Molecular Genetics and Microbiology, University of Texas, Austin, TX 78712.
Raj K PanditaDepartment of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA.
Vijaya K CharakaDepartment of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA.
Tej K PanditaDepartment of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA.
Michael B KastanDepartments of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Cheryl Lyn WalkerCenter for Translational Cancer Research, Institute for Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA.
Texas A&M University · USHouston Methodist · USHoward Hughes Medical Institute · USDuke Medical Center · USKorea Institute of Oriental Medicine · KRMethodist Hospital · USSt. Jude Children's Research Hospital · USThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
TARGETED GENOMICS FACILITY COREP30ES023512 · NIEHS · TEXAS A&M AGRILIFE RESEARCH · PI DEUTZ, NICOLAAS E · 2014 to 2017
$3.3M
CHROMATIN MODIFYING FACTORS CONTROL RADIATION RESPONSE AND GENOMIC STABILITYR01CA129537 · NCI · WASHINGTON UNIVERSITY · PI PANDITA, TEJ K · 2008 to 2018
$3.3M
Tumor Suppressor Localization and Function at the PeroxisomeR01CA143811 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WALKER, CHERYL L. · 2010 to 2018
$2.9M
Tumor-cell-specific targets for combined hyperthermia and radiation effectsR01CA154320 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI PANDITA, TEJ K · 2010 to 2014
$1.6M
Role of Heterochromatin protein 1 Beta in Genome Maintenance and OncogenesisR01GM109768 · NIGMS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI PANDITA, TEJ K · 2014 to 2017
$1.2M
NCI NIH HHS CA129537NCI NIH HHS CA154320NCI NIH HHS R01 CA129537NCI NIH HHS R01 CA143811NCI NIH HHS R01 CA154320NIEHS NIH HHS P30 ES023512NIGMS NIH HHS GM109768NIGMS NIH HHS R01 GM109768
6 · The paper itself

Abstract

Peroxisomes are highly metabolic, autonomously replicating organelles that generate reactive oxygen species (ROS) as a by-product of fatty acid β-oxidation. Consequently, cells must maintain peroxisome homeostasis, or risk pathologies associated with too few peroxisomes, such as peroxisome biogenesis disorders, or too many peroxisomes, inducing oxidative damage and promoting diseases such as cancer. We report that the PEX5 peroxisome import receptor binds ataxia-telangiectasia mutated (ATM) and localizes this kinase to the peroxisome. In response to ROS, ATM signalling activates ULK1 and inhibits mTORC1 to induce autophagy. Specificity for autophagy of peroxisomes (pexophagy) is provided by ATM phosphorylation of PEX5 at Ser 141, which promotes PEX5 monoubiquitylation at Lys 209, and recognition of ubiquitylated PEX5 by the autophagy adaptor protein p62, directing the autophagosome to peroxisomes to induce pexophagy. These data reveal an important new role for ATM in metabolism as a sensor of ROS that regulates pexophagy.

Indexed as

AutophagyAdaptor Proteins, Signal TransducingAnimalsAtaxia Telangiectasia Mutated ProteinsBlotting, WesternCells, CulturedHEK293 CellsHep G2 CellsHumansHydrogen PeroxideMCF-7 CellsMechanistic Target of Rapamycin Complex 1Mice, KnockoutMicroscopy, ElectronMicroscopy, FluorescenceMultiprotein ComplexesAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATM protein, humanHydrogen PeroxideMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPeroxisome-Targeting Signal 1 ReceptorPEX5 protein, humanPex5 protein, mouseReactive Oxygen SpeciesReceptors, Cytoplasmic and NuclearSequestosome-1 ProteinSerineSQSTM1 protein, humanTOR Serine-Threonine Kinases

Identifiers

PMID26344566
PMCPMC4589490
OpenAlexW1875936957

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.